Overview
Satoru Ueno practices practicing medicine in Izumi, Japan.
His clinical expertise encompasses Late-Onset Retinal Degeneration, Interstitial Keratitis, and Ganglion Cyst.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Osaka, 5848585, Japan
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Satoru Ueno
Is Satoru Ueno a top-rated expert for Late-Onset Retinal Degeneration?
MediFind is an objective health platform that identifies experts based on real-world data. Satoru Ueno is classified as an Experienced expert for Late-Onset Retinal Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Satoru Ueno participate in research or clinical trials?
Yes. Satoru Ueno has published 8 articles and abstracts on conditions like Late-Onset Retinal Degeneration. You can view a list of Satoru Ueno's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Ganglion CystMr. Ueno isExperienced. Learn about Ganglion Cyst.
- Interstitial KeratitisMr. Ueno isExperienced. Learn about Interstitial Keratitis.
- Late-Onset Retinal DegenerationMr. Ueno isExperienced. Learn about Late-Onset Retinal Degeneration.